Literature DB >> 8026525

A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.

M Hengstschläger1, M Williams, N Maizels.   

Abstract

To identify cis-acting elements responsible for targeting somatic hypermutation to immunoglobulin variable regions, we generated transgenic mice which carry a rearranged lambda 1 gene regulated by the heavy chain intron enhancer, E mu, and the heavy chain promoter PH186.2 from the VH186.2 variable region. C57BL/6 x SJL founders were bred with C57BL/6 mice to establish a line carrying a single copy of the transgene. Somatic hypermutation was studied by generating hybridoma cell lines from mice immunized with the hapten (4-hydroxy-3-nitrophenyl)acetyl (NP) coupled to chicken gamma globulin. The immune response in this transgenic line was dominated by the endogenous VH186.2 heavy chain variable region and the transgenic lambda 1 light chain, and the transgene was actively expressed in all hybridomas analyzed. In this work we show that the transgenic V lambda 1 regions do not undergo hypermutation, despite high levels of expression, while the expressed heavy chain V regions accumulate mutations at a rate typical of the NP response in C57BL/6 mice. Thus, within the same B cell, the PH186.2 promoter in connection with E mu drives efficient expression of both a VH and a V lambda region, but only the VH is a target for somatic hypermutation. Our observations show that cis-acting sequences that activate immunoglobulin gene transcription are not sufficient to target somatic hypermutation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026525     DOI: 10.1002/eji.1830240729

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

Review 1.  The reverse transcriptase model of somatic hypermutation.

Authors:  E J Steele; R V Blanden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

2.  DNA breaks in hypermutating immunoglobulin genes: evidence for a break-and-repair pathway of somatic hypermutation.

Authors:  Q Kong; N Maizels
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

3.  Raising the sensitivity of fetal RhD typing and sex determination from maternal blood.

Authors:  M Hengstschläger; G Hölzl; B Ulm; G Bernaschek
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.